Skip to main content
Log in

A necrotic groin mass in a patient with systemic diffuse large B-cell lymphoma

  • Residents’ Corner
  • Published:
European Journal of Dermatology

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Akyol P, Albayrak M, Maral S, et al. Diffuse large B cell lymphoma progression with skin involvement: a case report. J Tissue Viability 2020; 29(3): 216–7.

    Article  Google Scholar 

  2. Sehn LH, Salles G. Diffuse large B-cell lymphoma. N Engl J Med 2021; 384(9): 842–58.

    Article  CAS  Google Scholar 

  3. Tilly H. Diffuse large B-cell lymphoma: ESMO clinical practice guidelines. Ann Oncol 2015; 26: v116–25.

    Article  Google Scholar 

  4. Martelli M, Ferreri AJ, Agostinelli C, et al. Diffuse large B-cell lymphoma. Crit Rev Oncol Hematol 2013; 87: 146–71.

    Article  Google Scholar 

  5. Santucci M, Pimpinelli N. Primary cutaneous B-cell lymphomas. Current concepts. I. Haematologica 2004; 89(11): 1360–71.

    PubMed  Google Scholar 

  6. Wilcox RA. Cutaneous B-cell lymphomas: 2019 update on diagnosis, risk stratification, and management. Am J Hematol 2018; 93(11): 1427–30.

    Article  Google Scholar 

  7. Shamsudin N, Chang CC. Diffuse large B-cell lymphoma presenting with extensive cutaneous infiltration. Singapore Med J 2012; 53(9): e198–200.

    PubMed  Google Scholar 

  8. Lee WJ, Won KH, Won CH, et al. Secondary cutaneous diffuse large B-cell Lymphoma has a Higher International Prognostic Index Score and worse prognosis than diffuse large B-cell Lymphoma, leg type. Acta Derm Venereol 2016; 96: 245–50.

    Article  CAS  Google Scholar 

  9. Zackheim HS, Vonderheid EC, Ramsay DL, LeBoit PE, Rothfleisch J, Kashani-Sabet M. Relative frequency of various forms of primary cutaneous lymphomas. J Am Acad Dermatol 2000; 43(5 Pt 1): 793–6.

    Article  CAS  Google Scholar 

  10. Maurer MJ, Ghesquières H, Jais J-P, et al. Event-free survival at 24 months is a robust end point for disease-related outcome in diffuse large B-cell lymphoma treated with immunochemotherapy. J Clin Oncol 2014; 32: 1066–73.

    Article  Google Scholar 

  11. Cheson BD, Fisher RI, Barrington SF, et al. Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification. J Clin Oncol 2014; 32: 3059–68.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Neda Alband.

Additional information

Disclosures

Patient consent: obtained. Conflicts of interest: none.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Alband, N., Yethenpa, S., McDonald, S. et al. A necrotic groin mass in a patient with systemic diffuse large B-cell lymphoma. Eur J Dermatol 31, 427–429 (2021). https://doi.org/10.1684/ejd.2021.4071

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1684/ejd.2021.4071

Navigation